Cigna EVP Neville sells $175K in stock under plan

Cigna Group’s EVP and special advisor to the CEO sold 617 CI shares under a pre-arranged Rule 10b5-1 trading plan and now directly holds 5,053 shares.

Rhea-AI Filing Summary

Cigna Group (CI) reported that executive vice president and special advisor to the CEO Everett Neville sold 617 shares of common stock on September 3, 2026 in an open-market or private transaction at $284.05 per share, pursuant to a Rule 10b5-1 trading plan adopted on June 2, 2026. Following this sale, he directly holds 5,053 shares of Cigna Group common stock.

Insider Trade Summary 10b5-1

Net Seller: 617 shares

Net Sell 1 txn

Insider Neville Everett

Role See Remarks

Sold 617 shs ($175K)

Type	Security	Shares	Price	Value
Sale	Common Stock, $.01 Par Value F1	617	$284.05	$175K

Holdings After Transaction: Common Stock, $.01 Par Value — 5,053 shares (Direct)

Footnotes (1)

1. F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2026.

Key Figures

Shares sold: 617 shares Sale price per share: $284.05 per share Approximate transaction value: $175,258.85 +2 more

5 metrics

Shares sold 617 shares Common stock sale by executive on September 3, 2026

Sale price per share $284.05 per share Price for the 617 Cigna common shares sold

Approximate transaction value $175,258.85 617 shares sold at $284.05 per share

Shares held after transaction 5,053 shares Direct Cigna common stock holdings after the sale

Rule 10b5-1 plan adoption date June 2, 2026 Date the reporting person adopted the trading plan used for this sale

Key Terms

Rule 10b5-1 trading plan, open market or private transaction, special advisor to the CEO

3 terms

Rule 10b5-1 trading plan regulatory

"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2026."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

open market or private transaction market

"The filing describes the sale as a sale in an open market or private transaction."

special advisor to the CEO other

"Everett Neville is identified as EVP, special advisor to the CEO."

FAQ

What insider transaction did Cigna Group (CI) disclose for Everett Neville?

Cigna Group disclosed that executive vice president and special advisor to the CEO Everett Neville sold 617 shares of Cigna common stock on September 3, 2026 in an open-market or private transaction at $284.05 per share.

How many Cigna Group (CI) shares does Everett Neville hold after the reported sale?

After the reported transaction, Everett Neville directly holds 5,053 shares of Cigna Group common stock, as stated in the filing’s post-transaction ownership figure.

What was the approximate dollar value of Everett Neville’s Cigna (CI) share sale?

The sale involved 617 shares at $284.05 per share, for an approximate total value of $175,258.85, based on the reported share count and price.

Was Everett Neville’s Cigna (CI) share sale made under a Rule 10b5-1 trading plan?

Yes. The filing notes the transaction was effected pursuant to a Rule 10b5-1 trading plan that Everett Neville adopted on June 2, 2026, indicating the sale was pre-arranged under that plan.

What role does Everett Neville hold at Cigna Group (CI)?

Everett Neville is identified as an executive vice president and special advisor to the CEO of Cigna Group in the remarks section of the Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/08/2026 - 04:29 PM Accepted by SEC EDGAR 09/08/2026 - 04:29 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Neville Everett

(Last) (First) (Middle)

900 COTTAGE GROVE RD

(Street)

BLOOMFIELD CONNECTICUT 06002

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cigna Group [ CI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $.01 Par Value	09/03/2026		S		617	D(1)	$284.05	5,053	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2026.

Remarks:

EVP, Special Advisor to the CEO

	Tyler Gratton, attorney-in-fact	09/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)